Literature DB >> 6332821

Purification of human interleukin 1 by high-performance liquid chromatography.

A Köck, T A Luger.   

Abstract

The utility of high-performance liquid chromatography (HPLC) in the purification of Interleukin 1 (IL 1, lymphocyte-activating factor) has been investigated Human IL 1-containing supernatants were concentrated by lyophilization and desalted using Bio-Gel P-6 DG desalting gel. Subsequently, the sample containing IL 1 activity was subjected to HPLC with a novel HPHT hydroxylapatite column. Using a sodium phosphate gradient, IL 1 was eluted as a single peak of activity separated from the major protein contaminant, yielding 90% recovery and a specific activity of 6.3 X 10(4) U/mg. Pooled fractions from Bio-Gel HPHT were concentrated and subjected either to Bio-Sil IEX 540 DEAE anion-exchange or Bio-Sil TSK 125 size exclusion chromatography. From DEAE the IL 1 activity was eluted before a linear sodium chloride gradient was started, whereas the protein contaminant was eluted at 110 mM NaCl. When TSK was used IL 1 activity was eluted within a molecular weight range of 20,000-10,000. Fractions from the DEAE or TSK columns that were positive for IL 1 activity did not contain detectable protein, suggesting a good resolution. Furthermore, the recovery from DEAE was 26% whereas TSK 125 yielded 119% of the original activity. The specific activities were 6 X 10(7) and 2.5 X 10(8) U/mg, respectively. Thus, this method provides a rapid and reproducible procedure for the purification if IL 1 for further biological characterization.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6332821     DOI: 10.1016/s0021-9673(01)96423-4

Source DB:  PubMed          Journal:  J Chromatogr


  3 in total

1.  The role of interleukin-1 in neutrophil leukocyte emigration induced by endotoxin.

Authors:  M I Cybulsky; I G Colditz; H Z Movat
Journal:  Am J Pathol       Date:  1986-09       Impact factor: 4.307

2.  Purification to homogeneity and amino acid sequence analysis of two anionic species of human interleukin 1.

Authors:  P M Cameron; G A Limjuco; J Chin; L Silberstein; J A Schmidt
Journal:  J Exp Med       Date:  1986-07-01       Impact factor: 14.307

3.  Characterization of a monoclonal antibody directed against the biologically active site of human interleukin 1.

Authors:  A Köck; M Danner; B M Stadler; T A Luger
Journal:  J Exp Med       Date:  1986-02-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.